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Stereoselective synthesis of 1,3-disubstituted
dihydroisoquinolines via L-phenylalanine-derived
dihydroisoquinoline N-oxides†
Jesús Flores-Ferrándiz, Nicholas Carter, Maria José González-Soria,
Malgorzata Wasinska, Daniel Gill, Beatriz Maciá * and Vittorio Caprio*
The preparation of chiral pool-derived nitrone 3 and its use in the protecting-group free, stereoselective
synthesis of a range of 1,3-disubstituted tetrahydroisoquinolines is described. Grignard reagent additions
to nitrone 3 yielded trans-1,3-disubstituted N-hydroxytetrahydroisoquinolines 6 with good levels of
selectivity, while 1,3-dipolar cycloadditions to this nitrone provided access to 3-(2-hydroxyalkyl)isoquino-
lines 12 as single diastereomers.
Introduction
Tetrahydroisoquinoline (THIQ) systems occur in a wide range
of natural products and therapeutic drugs1 and have been
highlighted both as privileged scaﬀolds2 and as useful moi-
eties in fragment-based drug discovery.3 Moreover, there is
interest in the use of tetrahydroisoquinolines as ligands in
asymmetric catalysis4 and as chiral bases.5 The methods for
accessing 1,3-disubstituted THIQ’s, can be broadly grouped
into two strategies, based on either cyclisations of suitably sub-
stituted aromatic precursors6 or functionalisation of isoquino-
line-based scaﬀolds.7 In an eﬀort to develop a strategy towards
enantiodefined tetrahydroisoquinolines, of general use, we
became interested in an approach of the latter type utilizing a
chiral pool-derived isoquinoline unit with a potentially broad
reactivity profile. The only previous approaches with these cri-
teria utilize either 1-lithiated derivative 18 or imine 25 – with
reactivity restricted to additions to electrophiles or nucleo-
philes respectively (Fig. 1).
We envisaged that nitrone 3 would exhibit much utility in
this regard. The core scaﬀold is readily accessible, in enantio-
enriched form from L-phenylalanine, and the reactivity of the
nitrone group, functionalised via 1,3-dipolar cycloaddition,9
nucleophilic addition10 and reductive coupling with electro-
philes,11 confers wide scope to this system (Scheme 1).
Furthermore, the hydroxymethyl group functions as a readily
removable stereocontrol element.12
Results and discussion
Preparation of nitrone 3
Our approach to nitrone 3 centred on the oxidation of the
known amine 5 (Scheme 2), accessed by Pictet–Spengler reac-
tion of L-phenylalanine,13 followed by borane-mediated
reduction of the resulting acid.5 Trialing a range of methods
for the direct oxidative conversion of amines to nitrones,
revealed that the corresponding isoquinoline N-oxide was a
significant byproduct. Best results were achieved using Oxone
as oxidant, providing dihydroisoquinoline derived nitrone 3
cleanly, in moderate yield (58%), with no evidence of overoxi-
dation to the corresponding isoquinoline N-oxide.14
Fig. 1 Previous chiral pool-derived THIQ precursors.
Scheme 1 Synthetic approaches to 1,3-disubstituted tetrahydroiso-
quinolines utilising nitrone 3.
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c8ob02007h
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Addition of organometallic reagents to nitrone 3
With nitrone 3 in hand, the nucleophilic addition of organo-
metallic reagents was initially investigated by screening of a
range of solvents and temperatures, using methylmagnesium
bromide and methyllithium as test reagents (Table 1). In all
cases, full conversion was achieved using 3 equivalents of
nucleophile, with the 1,3-trans isomer 6a as the major product.
THF provided the best diastereomeric ratios and no advantage
was conferred by performing the reaction under cryogenic con-
ditions see (entries 7–9). It is noteworthy that, while the
addition of the more reactive methyllithium proceeded with
full conversion, stereoselectivity was lower than that obtained
with the corresponding Grignard reagent (entry 10 vs. entry 7).
Consequently, subsequent studies were performed using
Grignard species under the conditions outlined in entry 7.
The addition of diﬀerent Grignard reagents to nitrone 3
provided, in all cases, the trans-isomer 6 as the major product
(Table 2). No discernable trends are evident in Table 2,
although the best levels of selectivity were obtained with the
larger phenylmagnesium bromide (entry 5). Cis/trans stereo-
chemistry of products 6 and 7 was assigned by 2D NOESY ana-
lysis (see Fig. 2 for an example). Strong correlations between
the protons of the C1-substituent and H3 were observed in the
trans-adduct, while the trans-diaxial correlations between H1
and H3 revealed the cis-diequatorial substitution pattern of the
minor adduct, as illustrated on the ethyl-adduct 6b/7b.
The eﬀect of protection of the 3-hydroxymethyl group, in
combination with increasing size of the 3-substituent, was
investigated by studying the addition of diﬀerent Grignard
reagents to the TBS-protected nitrone 8 (Table 3), prepared by
sodium tungstate-catalysed-oxidation of the known TBS-deriva-
tive of hydroxymethyl-THIQ 5.5,15 The addition of both ethyl-
and phenylmagnesium bromide to 8 proceeded in favour of
the trans-adducts 9, but with much lower selectivities than
those obtained with the unprotected nitrone 3 (compare
Table 3, entries 1 and 2 with Table 2, entries 2 and 5,
respectively).
These results indicate that, in addition to the metal, (see
Table 1, entries 7 and 10, for the addition of MeMgBr and
Table 1 Optimization of the addition of organometallic reagents to
nitrone 3a
Entry RM Solvent T (°C) 6a/7ab Conv.c (%)
1 MeMgBr CH2Cl2 0 4.5/1 >99
2 MeMgBr PhMe 0 7.1/1 >99
3 MeMgBr Dioxane 0 3.0/1 >99
4 MeMgBr tBuOMe 0 3.5/1 >99
5 MeMgBr Et2O 0 5.5/1 >99
6 MeMgBr THF 20 6.0/1 >99
7 MeMgBr THF 0 7.5/1 >99
8 MeMgBr THF −20 7.5/1 >99
9 MeMgBr THF −40 7.5/1 >99
10 MeLi THF 0 3.8/1 >99
a Reaction conditions: 3 (0.1 mmol), RM (3 eq.), T, solvent. b Ratio
determined by analysis of 1H-NMR spectra of crude products. Relative
stereochemistry determined by 2D-NOESY studies; see ESI for further
details. cDetermined by 1H-NMR analysis of crude products.
Table 2 Addition of organometallic reagents to nitrone 3a
Entry RM Products 6 : 7a,b Yieldc (%)
1 MeMgBr 6a/7a 7.5/1 75
2 EtMgBr 6b/7b 6.5/1 87
3 iPrMgBr 6c/7c 5.9/1 85
4 AllylMgBr 6d/7d 2.8/1 90
5 PhMgBr 6e/7e 10/1 96
a Reaction conditions: 3 (0.3 mmol), RMgBr (3 eq.), THF, 0 °C to r.t.
b Ratio determined by analysis of crude 1H-NMR spectra. Relative
stereochemistry determined by 2D-NOESY studies, see Fig. 2 and ESI
for further details. c Isolated combined yield after column
chromatography.
Fig. 2 Selected correlations observed in the 2D-NOESY spectra of tet-
rahydroisoquinolines 6b and 7b.
Table 3 Addition of organometallic reagents to nitrone 8a
Entry RM Product 9/10b Yieldc (%)
1 EtMgBr 9a/10a 2.5/1 56
2 PhMgBr 9b/10b 3/1 53
a Reaction conditions: 8 (0.3 mmol), RMgBr (3 eq.), THF, 0 °C to r.t.
b Ratio determined by 1H-NMR on the reaction crude. Relative stereo-
chemistry determined by 2D-NOESY studies. c Isolated combined yield
after column chromatography.
Scheme 2 Synthesis of nitrone 3.
Paper Organic & Biomolecular Chemistry
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MeLi, respectively), the nitrone oxygen and the free hydroxyl
group play an important role in determining the mode and
level of diastereoselectivity in the addition to 3. This hypoth-
esis is supported by the results obtained with imine 2, where
the selectivities of the addition of organolithium species are
generally lower than those reported in Table 2 for all but the
largest nucleophiles.5 We propose the model depicted in Fig. 3
to account for this selectivity, which involves a cyclic mag-
nesium chelate similar to that hypothesized during additions
to N-glycosyl nitrones.16 In our model, the syn addition is hin-
dered by the pseudo-axial proton at C4.
Cycloaddition reactions of nitrone 3
Next, the preparation of more functionalized, stereodefined
1,3-THIQ systems was investigated via 1,3-dipolar cyclo-
addition of 3 with a range of alkenes, followed by reduction of
the resulting isoxazolidines 11 (Table 4). Styrene and hex-1-ene
were chosen as the prototypical model dipolarophiles (entries
1 and 2), alongside functionalized butenes, selected to access
products of subsequent synthetic utility (entries 3 and 4).
Optimum yields/selectivity were obtained in toluene under
reflux conditions. The stereochemistry of the cycloaddition
was readily deduced by analysis of 2D-NOESY spectra of cyclo-
adducts 11 (see an example in Fig. 4), which revealed strong
correlations between H2/H6 and H10b/CH2(OH). In all cases,
the exo-1,3-trans-isoxazolidine was exclusively obtained in
moderate to good yield and no traces of any other isomers
were detected in the 1H NMR spectra of crude products. The
cycloaddition reactions of nitrone 3 with a range of electron
deficient systems, including acrylates, were trialed but, unfor-
tunately, failed to provide the corresponding cycloadducts.
The subsequent reductive N–O bond cleavage of isoxazoli-
dine 11, with zinc powder in AcOH, proceeded with no stereo-
chemical degradation,17 providing the corresponding 1,3-THIQ
12a–d in good to moderate yields (Table 2).
Conclusions
In conclusion, we have developed an approach to the synthesis
of a range of optically active 1,3-disubstituted tetrahydroisoqui-
nolines from (S)-3-(hydroxymethyl)-3,4-dihydroisoquinoline
2-oxide 3. The addition of Grignard reagents to 3 proceeded
with good yields and stereoselectivities, and unprecedented
levels of stereoselection were found for the dipolar cyclo-
addition reaction of alkenes to nitrone 3. This strategy allows
the direct assembly of highly functionalized tetrahydroiso-
quinoline units with up to three stereogenic centres in a
simple and eﬀective manner, starting from a readily available
chiral substrate.
Experimental
General
1H NMR and 13C NMR have been recorded on a JEOL®
ECS-400 (400 and 100.6 MHz, respectively) using CDCl3 as
solvent. Chemical shift values are reported in ppm with TMS
as internal standard (CDCl3: δ 7.26 for
1H-NMR, δ 77.0 for
13C-NMR). Data are reported as follows: chemical shifts, multi-
plicity (s = singlet, quint = quintuplet, m = multiplet), coupling
constants (Hz), and integration. IR spectra were recorded on
Nicolet® 380 FT/IR – Fourier Transform Infrared Spectrometer.
Only the most significant frequencies have been considered
during the characterization, and have been reported in cm−1.
High resolution mass spectra were measured on an Agilent
Technologies® 6540 Ultra-High-Definition (UHD) Accurate-
Mass equipped with a time of flight (Q-TOF) analyzer and the
samples were ionized by ESI techniques and introduced
through a high pressure liquid chromatography (HPLC) model
Agilent Technologies® 1260 Infinity Quaternary LC system.
Optical rotations were measured on a Bellingham + Stanley®
Fig. 3 Proposed mode of addition of Grignard reagents to nitrone 3.
Table 4 Cycloaddition of nitrone 3 and reduction of cycloadducts 11a
Entry R Product 11b (% yield) 12b (% yield)
1 Ph 11a/12a 86 33
2 (CH2)3CH3 11b/12b 74 90
3 (CH2)2OBn 11c/12c 61 51
4 (CH2)2SPh 11d/12d 64 47
a Reaction conditions: (i) CH2vCH2R (5 eq.), toluene, 110 °C; (ii)
AcOH, Zn, reflux. b Isolated yield after flash chromatography. Relative
stereochemistry determined by 2D-NOESY studies, see Fig. 4 and ESI
for further details.
Fig. 4 Selected correlations observed in the 2D-NOESY spectrum
of 11a.
Organic & Biomolecular Chemistry Paper
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ADP 440 + Polarimeter with a 0.5 cm cell (c given in g per
100 mL).
All reactions were monitored by thin-layer chromatography
using precoated sheets of silica gel 60, 0.25 mm thick (F254
Merck KGaA®). The components were visualized by UV light
(254 nm) and phosphomolybdic acid. Flash column chromato-
graphy was done using Geduran® Silica gel 60, 40–63 microns
RE. The eluent used is mentioned in each particular case. All
glassware employed during inert atmosphere experiments was
flame-dried under a stream of dry argon. Alkenes reagents
were purchased from Sigma-Aldrich or Fisher Scientific and
used without further purification. Grignard and organolithium
reagents were purchased from Sigma-Aldrich. Anhydrous THF
was obtained from a Pure Solv™ Solvent Purification Systems.
(S)-3-(Hydroxymethyl)-3,4-dihydroisoquinoline-2-oxide (3).
NaHCO3 (6.72 g, 80.0 mmol) was added to a solution of tetra-
hydroisoquinoline 5 (2.6 g, 16.0 mmol) in THF–CH3CN 1 : 4
(28 mL) and 0.01 M aqueous EDTA solution (22.4 mL) at 5 °C.
Oxone (10.3 g, 16.8 mmol) was then added portionwise over
2 h, and the mixture stirred for 20 min, at 5 °C. Ethyl acetate
(80 mL) was added and the aqueous layer further extracted
with ethyl acetate (2 × 80 mL). The combined organic extracts
were dried over anhydrous MgSO4 and concentrated under
reduced pressure to give nitrone 3 (1.66 g, 59%) as a pale
yellow solid; m.p. decomposes T > 145 °C; [α]25D 174 (c = 3.3,
CHCl3); IR (ATR): ν = 3242, 3054, 2945, 2897 cm
−1; 1H NMR
(400 MHz, CDCl3): δH = 7.80 (s, 1H), 7.35–7.25 (m, 2H),
7.25–7.20 (m, 1H), 7.18–7.14 (m, 1H), 4.51 (br s, 1H), 4.26–4.16
(m, 1H), 4.04 (dd, J = 12.0, 6.9 Hz, 1H), 3.94 (dd, J = 12.0,
3.6 Hz, 1H), 3.22–3.07 (m, 2H) ppm; 13C NMR (101 MHz,
CDCl3): δC = 135.4, 130.0, 129.8, 127.6, 127.5, 127.2, 125.6,
67.2, 62.7, 29.8 ppm; MS (EI, 70 eV): m/z (%) = 177 (M+, 8), 130
(100), 115 (34), 103 (22), 77 (26); HRMS (ESI-MeOH): m/z calcd
for C10H12NO2 [M + H]
+: 178.0863 found 178.0862.
General procedure for the diastereoselective addition of
Grignard reagents
A solution of RMgBr (0.9 mmol, 3 eq.) was added to a solution
of nitrone 3 (53.1 mg, 0.3 mmol) in THF (1.5 mL). The mixture
was stirred at 0 °C for 1 h and then warmed to room tempera-
ture and quenched with water. The mixture was extracted with
EtOAc (3 × 10 mL) and the combined organic phases dried
over MgSO4, and concentrated under reduced pressure. The
crude product, was purified by flash column chromatography
eluting with n-hexane/EtOAc (gradient from 10 to 60%) to give
the corresponding 1,3-disubstituted tetrahydroisoquinoline-2-
ol as a yellow oil.
(1R,3S)-3-(Hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-
2(1H)-ol (6a) and (1S,3S)-3-(hydroxymethyl)-1-methyl-3,4-dihy-
droisoquinolin-2(1H)-ol (7a). Following the general procedure,
the reaction of methylmagnesium bromide (3.0 M in Et2O,
300 μL) with nitrone 3 gave the 1,3-disubstituted tetrahydroiso-
quinoline-2-ol 6a (38 mg, 66% yield) as a yellow oil. [α]25D −15
(c = 1, CHCl3); IR (ATR): ν = 3240, 3019, 2973, 2932 cm
−1; 1H
NMR (400 MHz, CDCl3): δH = 7.17–7.10 (m, 2H), 7.10–7.01 (m,
2H), 4.32 (q, J = 7.1, 1H), 3.82 (dd, J = 11.5, 7.6 Hz, 1H), 3.72
(br s, 1H), 3.41–3.34 (m, 1H), 2.93 (dd, J = 16.7, 11.5 Hz, 1H),
2.53 (d, J = 14.8 Hz, 1H), 1.41 (d, J = 7.1 Hz, 3H) ppm; 13C NMR
(101 MHz, CDCl3): δC = 137.6, 132.2, 128.7, 127.3, 126.4, 126.2,
63.2, 62.4, 56.5, 25.8, 21.0 ppm; HRMS (ESI-MeOH): m/z calcd
for C11H16NO2 [M + H]
+: 194.1176 found 194.1778. 7a (5 mg,
9% yield) as a yellow oil. [α]25D −27 (c = 1, CHCl3); IR (ATR): ν =
3257, 2981, 2930, 2880 cm−1; 1H NMR (400 MHz, CDCl3): δH =
7.22–7.11 (m, 3H), 7.10–7.04 (m, 1H), 4.06 (q, J = 6.6 Hz, 1H),
3.82–3.78 (m, 2H), 3.16 (brs, 1H), 3.03 (dd, J = 16.2, 12.1 Hz,
1H), 2.65 (d, J = 14.8 Hz, 1H), 1.61 (d, J = 6.6 Hz, 3H) ppm; 13C
NMR (101 MHz, CDCl3): δC = 137.2, 133.0, 128.2, 126.6, 126.4,
126.0, 64.3, 64.0, 62.6, 29.7, 18.4 ppm; HRMS (ESI-MeOH): m/z
calcd for C11H16NO2 [M + H]
+: 194.1176 found 194.1177.
(1R,3S)-1-Ethyl-3-(hydroxymethyl)-3,4-dihydroisoquinolin-2
(1H)-ol (6b) and (1S,3S)-1-ethyl-3-(hydroxymethyl)-3,4-dihy-
droisoquinolin-2(1H)-ol (7b). Following the general procedure,
the reaction of ethylmagnesium bromide (3.0 M in Et2O,
300 μL) with nitrone 3 gave the 1,3-disubstituted tetrahydroiso-
quinoline-2-ol 6b (47 mg, 76% yield) as a yellow oil. [α]25D +3
(c = 1, CHCl3); IR (ATR): ν = 3285, 3062, 2931, 2873 cm
−1;
1H NMR (400 MHz, CDCl3): δH = 7.20–7.12 (m, 2H), 7.10–7.07
(m, 2H), 4.07 (t, J = 7.5 Hz, 1H), 3.84 (dd, J = 10.2, 9.0 Hz, 1H),
3.68 (dd, J = 11.0, 3.5 Hz, 1H), 3.40–3.33 (m, 1H), 2.90 (dd, J =
16.7, 11.7 Hz, 1H), 2.52 (dd, J = 16.7, 5.0 Hz, 1H), 1.76–1.63 (m,
2H), 1.10 (t, J = 7.5 Hz, 3H) ppm; 13C NMR (101 MHz, CDCl3):
δC = 136.7, 132.4, 128.8, 127.8, 126.4, 126.0, 68.9, 63.1, 56.2,
29.4, 24.6, 11.9 ppm; HRMS (ESI-MeOH): m/z calcd for
C12H18NO2 [M + H]
+: 208.1332 found 208.1334. 7b (7 mg, 11%
yield) as a yellow oil. [α]25D −29 (c = 1, CHCl3); IR (ATR): ν =
3279, 2961, 2931, 2873 cm−1; 1H NMR (400 MHz, CDCl3): δH =
7.22–7.11 (m, 3H), 7.08 (d, J = 7.1 Hz, 1H), 4.00 (t, J = 4.6 Hz,
1H), 3.81 (d, J = 4.9 Hz, 2H), 3.17–3.09 (m, 1H), 2.96 (dd, J =
16.1, 12.0 Hz, 1H), 2.64 (dd, J = 16.1, 4.0 Hz, 1H), 2.29–2.17
(m, 1H), 2.01–1.89 (m, 1H), 0.92 (t, J = 7.3 Hz, 1H) ppm; 13C
NMR (101 MHz, CDCl3): δC = 136.0, 133.9, 128.2, 126.3, 126.3,
125.9, 67.7, 64.9, 63.4, 29.7, 24.1, 9.2 ppm; HRMS (ESI-MeOH):
m/z calcd for C12H18NO2 [M + H]
+: 208.1332 found 208.1334.
(1R,3S)-3-(Hydroxymethyl)-1-isopropyl-3,4-dihydroisoquinolin-
2(1H)-ol (6c) and (1S,3S)-3-(hydroxymethyl)-1-isopropyl-3,4-dihy-
droisoquinolin-2(1H)-ol (7c). Following the general procedure,
the reaction of isopropylmagnesium bromide (0.75 M in THF,
1.2 mL) with nitrone 3 gave the 1,3-disubstituted tetrahydroiso-
quinoline-2-ol 6c (48 mg, 73% yield) as a yellow oil. [α]25D +15
(c = 1, CHCl3); IR (ATR): ν = 3308, 3020, 2956, 2871 cm
−1; 1H
NMR (400 MHz, CDCl3): δH = 7.20–7.12 (m, 2H), 7.12–7.05 (m,
2H), 3.85 (dd, J = 11.3, 8.6 Hz, 1H), 3.79 (d, J = 8.7 Hz, 1H),
3.64 (dd, J = 11.3, 3.6 Hz, 1H), 3.46–3.35 (m, 1H), 2.81 (dd, J =
17.1, 11.3 Hz, 1H), 2.57 (dd, J = 17.1, 6.1 Hz, 1H), 1.85–1.70 (m,
1H), 1.09 (d, J = 6.7 Hz, 3H), 0.97 (d, J = 6.7 Hz, 3H) ppm;
13C NMR (101 MHz, CDCl3): δC = 135.0, 132.8, 129.3, 128.8,
126.5, 125.2, 73.3, 63.2, 56.2, 33.2, 24.5, 21.2, 20.8 ppm; HRMS
(ESI-MeOH): m/z calcd for C13H20NO2 [M + H]
+: 222.1489
found 222.1483. 7c (8 mg, 12% yield) as a yellow oil. [α]25D +88
(c = 1, CHCl3); IR (ATR): ν = 3311, 3020, 2956, 2871 cm
−1; 1H
NMR (400 MHz, CDCl3): δH = 7.22–7.07 (m, 4H), 4.12 (d, J =
3.7 Hz, 1H), 3.93 (dd, J = 11.1, 3.0 Hz, 1H), 3.72 (dd, J = 11.1,
Paper Organic & Biomolecular Chemistry
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4.5 Hz, 1H), 3.11–3.01 (m, 1H), 2.88 (dd, J = 15.6, 12.4 Hz, 1H),
2.59 (dd, J = 15.6, 3.2 Hz, 1H), 2.29–2.12 (m, 1H), 1.06 (d, J =
6.8 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H) ppm; 13C NMR (101 MHz,
CDCl3): δC = 136.8, 134.9, 127.5, 126.8, 126.1, 126.0, 73.8, 64.9,
63.7, 34.6, 30.9, 20.6, 17.9 ppm; HRMS (ESI-MeOH): m/z calcd
for C13H20NO2 [M + H]
+: 222.1489 found 222.1482.
(1R,3S)-1-Allyl-3-(hydroxymethyl)-3,4-dihydroisoquinolin-2(1H)-
ol (6d) and (1S,3S)-1-allyl-3-(hydroxymethyl)-3,4-dihydroisoquino-
lin-2(1H)-ol (7d). Following the general procedure, the reaction
of allylmagnesium bromide (1.0 M in Et2O, 900 μL) with
nitrone 3 gave the 1,3-disubstituted tetrahydroisoquinoline-2-
ol 6d (44 mg, 67% yield) as a yellow oil. [α]25D −51 (c = 1,
CHCl3); IR (ATR): ν = 3302, 3076, 3021, 2928, 2044 cm
−1; 1H
NMR (400 MHz, CDCl3): δH = 7.21–7.13 (m, 2H), 7.13–7.04 (m,
2H), 6.01–5.85 (m, 1H), 5.09–5.05 (m, 2H), 4.26 (t, J = 7.4 Hz,
1H), 3.83 (dd, J = 11.2, 8.4 Hz, 1H), 3.68 (dd, J = 11.2, 3.4 Hz,
1H), 3.44–3.35 (m, 1H), 2.92 (dd, J = 16.7, 11.7 Hz, 1H), 2.53
(dd, J = 16.7, 4.7 Hz, 1H), 2.49–2.39 (m, 2H) ppm; 13C NMR
(101 MHz, CDCl3): δC = 135.8, 135.5, 132.5, 128.8, 127.7, 126.6,
126.0, 117.1, 66.8, 63.1, 56.3, 40.6, 24.7 ppm; HRMS
(ESI-MeOH): m/z calcd for C13H18NO2 [M + H]
+: 220.1332
found 220.1325. 7d (15 mg, 23% yield) as a yellow oil. [α]25D −41
(c = 1, CHCl3); IR (ATR): ν = 3280, 3075, 3021, 2927, 2042 cm
−1;
1H NMR (400 MHz, CDCl3): δH = 7.26–7.14 (m, 3H), 7.14–7.06
(m, 1H), 6.02–5.87 (m, 1H), 5.16 (dd, J = 17.2, 1.6 Hz, 1H), 5.06
(d, J = 10.3 Hz, 1H), 4.15 (t, J = 5.7 Hz, 1H), 3.85–3.74 (m, 2H),
3.21–3.12 (m, 1H), 3.02–2.95 (m, 2H), 2.78–2.69 (m, 1H), 2.63
(dd, J = 16.3, 3.8 Hz, 1H) ppm; 13C NMR (101 MHz, CDCl3):
δC = 136.3, 135.8, 133.8, 128.4, 126.5, 126.4, 126.1, 116.4, 66.1,
64.6, 63.3, 36.8, 28.9 ppm; HRMS (ESI-MeOH): m/z calcd for
C13H18NO2 [M + H]
+: 220.1332 found 220.1326.
(1R,3S)-3-(Hydroxymethyl)-1-phenyl-3,4-dihydroisoquinolin-
2(1H)-ol (6e) and (1S,3S)-3-(hydroxymethyl)-1-phenyl-3,4-dihy-
droisoquinolin-2(1H)-ol (7e). Following the general procedure,
reaction of phenylmagnesium bromide (3.0 M in Et2O, 300 μL)
with nitrone 3 gave the 1,3-disubstituted tetrahydroisoquino-
line-2-ol 6e (67 mg, 87% yield) as a yellow oil. [α]25D −84 (c = 1,
CHCl3); IR (ATR): ν = 3240, 3061, 3026, 2889 cm
−1; 1H NMR
(400 MHz, CDCl3): δH = 7.29–7.24 (m, 3H), 7.23–7.18 (m, 2H),
7.18–7.12 (m, 1H), 7.12–7.06 (m, 2H), 6.91 (d, J = 7.6 Hz, 1H),
5.33 (s, 1H), 3.77 (dd, J = 11.4, 7.6 Hz, 1H), 3.55 (d, J = 9.2 Hz,
1H), 3.36–3.26 (m, 1H), 2.96 (dd, J = 16.9, 10.1 Hz, 1H), 2.70
(dd, J = 16.9, 5.1 Hz, 1H) ppm; 13C NMR (101 MHz, CDCl3):
δC = 140.6, 134.0, 133.3, 130.2, 129.0, 128.6, 128.2, 127.7,
127.0, 126.2, 70.3, 62.8, 56.7, 26.2 ppm; HRMS (ESI-MeOH):
m/z calcd for C16H18NO2 [M + H]
+: 256.1332 found 256.1336.
7e (6 mg, 9% yield) as a yellow oil. [α]25D +4.5 (c = 1, CHCl3); IR
(ATR): ν = 3238, 3061, 3025, 2890 cm−1; 1H NMR (400 MHz,
CDCl3): δH = 7.35–7.30 (m, 2H), 7.29–7.23 (m, 2H), 7.15–7.08
(m, 2H), 7.03–6.95 (m, 1H), 6.54 (d, J = 7.8 Hz, 1H), 5.35 (br s,
1H), 4.88 (s, 1H), 3.95–3.82 (m, 1H), 3.77 (dd, J = 11.8, 5.3 Hz,
1H), 3.21 (d, J = 11.8 Hz, 1H), 3.14 (dd, J = 27.5, 11.8 Hz, 2H),
2.82 (d, J = 15.6 Hz, 1H) ppm; 13C NMR (101 MHz, CDCl3): δC =
141.9, 136.6, 133.2, 130.3, 128.3, 128.2, 127.8, 127.7, 126.7,
125.9, 75.1, 64.8, 64.6, 31.6 ppm; HRMS (CI-CH4): m/z calcd for
C16H18NO2 [M + H]
+: 256.1332 found 256.1337.
(S)-3-(((tert-Butyldimethylsilyl)oxy)methyl)-3,4-dihydroiso-
quinoline 2-oxide (8). A solution of (S)-3-(((tert-butyldimethyl-
silyl)oxy)methyl)-3,4-dihydroisoquinoline5,15 (0.76 g, 2.77
mmol) was added to a solution of sodium tungstate (0.14 g,
0.046 mmol) in methanol (1 mL). A 30% aqueous solution of
H2O2 (1.0 mL, 8.31 mmol) was added at 0 °C over a period of
30 min and the reaction mixture was warmed to room temp-
erature and stirred overnight. The mixture was concentrated
under reduced pressure, diluted with brine and extracted with
CH2Cl2 (2 × 15 mL). The combined organic layers were dried
over anhydrous MgSO4, and concentrated under reduced
pressure. The residue was purified by column chromatography,
using CHCl3–CH3OH (10 : 1) as eluent, to give nitrone 10
(0.46 g, 57%) as a viscous oil. [α]25D −36 (c = 1, CHCl3); IR (ATR):
ν = 2952, 2927, 2883, 2855 cm−1; 1H NMR (400 MHz, CDCl3):
δH = 7.73 (s, 1H), 7.28–7.18 (m, 3H), 7.08 (d, J = 6.9 Hz, 1H),
4.16–4.08 (m, 1H), 3.96 (dd, J = 9.9, 3.8 Hz, 1H), 3.84 (dd, J =
9.9, 7.7 Hz, 1H), 3.42 (dd, J = 16.7, 7.3 Hz, 1H), 3.25 (dd, J =
16.8, 3.2 Hz, 1H), 0.79 (s, 9H), −0.01 (s, 3H), −0.03 (s, 3H)
ppm; 13C NMR (101 MHz, CDCl3): δC = 134.8, 129.6, 129.2,
127.7, 127.6, 127.2, 125.1, 68.8, 61.8, 29.2, 25.5, 18.0, −5.7,
−5.78 ppm; HRMS (ESI-MeOH): m/z calcd for C16H26NO2Si
[M + H]+: 292.1727 found 292.1734.
(1R,3S)-3-(((tert-Butyldimethylsilyl)oxy)methyl)-1-ethyl-3,4-
dihydroisoquinolin-2(1H)-ol (9a) and (1S,3S)-3-(((tert-butyldi-
methylsilyl)oxy)methyl)-1-ethyl-3,4-dihydroisoquinolin-2(1H)-
ol (10a). Following the general procedure, the reaction of ethyl-
magnesium bromide (3.0 M in Et2O, 300 μL) with nitrone 8
gave the 1,3-disubstituted tetrahydroisoquinoline-2-ol 9a
(38 mg, 40% yield) as a yellow solid; m.p. 50–51 °C; [α]25D −12
(c = 1.2, CHCl3); IR (ATR): ν = 3229, 3063, 2954, 2928, 2856,
1462, 1252, 1100, 834, 774, 748 cm−1; 1H NMR (400 MHz,
CDCl3): δH = 7.18–7.09 (m, 4H), 6.42 (br s, 1H), 4.05 (dd, J =
8.3, 6.3 Hz, 1H), 3.99 (dd, J = 10.0, 5.6 Hz, 1H), 3.79 (dd, J =
10.0, 6.1 Hz, 1H), 3.31 (td, J = 11.1, 5.6 Hz, 1H), 2.98 (dd, J =
16.7, 11.0 Hz, 1H), 2.66 (dd, J = 16.7, 5.2 Hz, 1H), 1.76–1.67 (m,
2H), 1.09 (t, J = 7.4Hz, 3H), 0.92 (s, 9H), 0.11 (s, 3H), 0.10 (s,
3H) ppm; 13C NMR (101 MHz, CDCl3): δC = 137.4, 133.3, 128.9,
127.8, 126.3, 126.0, 68.7, 65.5, 56.6, 29.7, 26.1, 25.6, 18.5, 11.9,
−5.1, −5.2 ppm; HRMS (ESI-EtOAc): m/z calcd for C18H31NO2Si
[M + H]+ 322.2202 found 322.2197. 10a (16 mg, 16% yield) as a
yellow oil. [α]25D −7 (c = 1.5, CHCl3); IR (ATR): ν = 3263, 3066,
2954, 2928, 2855, 1462, 1252, 1103, 834, 775, 739 cm−1; 1H
NMR (400 MHz, CDCl3): δH = 7.19–7.11 (m, 4H),5.05 (br s, 1H),
4.03 (dd, J = 10.0, 4.9 Hz, 1H), 3.96 (t, J = 4.6 Hz, 1H), 3.77 (dd,
J = 10.0, 6.2 Hz, 1H), 3.09 (m, 1H), 2.93–2.86 (m 1H), 2.79 (dd,
J = 16.2, 4.2 Hz, 1H), 2.28–2.17 (m, 1H), 1.98–187 (m, 1H), 0.92
(s, 9H), 0.89 (t, J = 7.2 Hz, 1H), 0.11 (s, 3H), 0.10 (s, 3H) ppm;
13C NMR (101 MHz, CDCl3): δC = 136.6, 134.6, 128.3, 126.3,
126.2, 126.0, 68.1, 66.1, 63.6, 29.9, 26.1, 24.6, 18.5, 9.2, −5.1,
−5.2 ppm; HRMS (ESI-EtOAc): m/z calcd for C18H31NO2Si
[M + H]+ 322.2202 found 322.2197.
(1R,3S)-3-(((tert-Butyldimethylsilyl)oxy)methyl)-1-phenyl-3,4-
dihydroisoquinolin-2(1H)-ol (9b) and (1S,3S)-3-(((tert-butyldi-
methylsilyl)oxy)methyl)-1-phenyl-3,4-dihydroisoquinolin-2(1H)-
(10b). Following the general procedure, the reaction of phenyl-
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magnesium bromide (3.0 M in Et2O, 300 μL) with nitrone 8
gave the 1,3-disubstituted tetrahydroisoquinoline-2-ol 9b
(44 mg, 40% yield) as a yellow oil. [α]25D −4 (c = 1, CHCl3); IR
(ATR): ν = 3213, 3062, 2927, 2855 cm−1; 1H NMR (400 MHz,
CDCl3): δH = 7.39–7.31 (m, 3H), 7.29–7.28 (m, 2H), 7.25–7.17
(m, 3H), 6.96 (d, J = 7.7 Hz, 1H), 6.92 (s, 1H), 5.28 (s, 1H), 4.06
(dd, J = 10.0, 5.2 Hz, 1H), 3.82 (dd, J = 10.0, 6.7 Hz, 1H),
3.48–3.40 (m, 1H), 3.14 (dd, J = 16.8, 8.3 Hz, 1H), 2.98 (dd, J =
16.8, 5.3 Hz, 1H), 0.92 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H) ppm;
13C NMR (101 MHz, CDCl3): δC = 141.8, 134.9, 133.7, 130.0,
128.9, 128.7, 128.1, 127.4, 126.7, 125.9, 70.0, 63.4, 57.5, 27.2,
25.8, 18.2, −5.4, −5.5 ppm; HRMS (ESI-MeOH): m/z calcd for
C22H32NO2Si [M + H]
+ 370.2197 found 370.2205. 10b (15 mg,
13% yield) as a yellow oil. [α]25D −55 (c = 1, CHCl3); IR (ATR): ν =
3306, 3028, 2927, 2854 cm−1; 1H NMR (400 MHz, CDCl3): δH =
7.39–7.34 (m, 5H), 7.16–7.11 (m, 2H), 7.04–6.97 (m, 1H), 6.59
(d, J = 7.8 Hz, 1H), 4.89 (s, 2H), 4.16 (dd, J = 9.9, 4.4 Hz, 1H),
3.79 (dd, J = 9.9, 6.9 Hz, 1H), 3.29–3.18 (m, 1H), 3.09 (s, 1H),
3.07 (s, 1H), 0.93 (s, 9H), 0.10 (s, 3H), 0.10 (s, 3H) ppm; 13C
NMR (101 MHz, CDCl3): δC = 142.9, 137.3, 133.5, 129.9, 128.4,
128.1, 127.8, 127.5, 126.5, 125.8, 74.7, 65.3, 64.1, 25.9, 22.7,
18.3, −5.2, −5.3 ppm; HRMS (ESI-MeOH): m/z calcd for
C22H32NO2Si [M + H]
+ 370.2197 found 370.2203.
General procedure for the cycloaddition reactions of nitrone 3
A solution of nitrone 3 (0.1 g, 0.56 mmol) in dry toluene
(5 mL) was heated to 80 °C. A solution of the corresponding
alkene (5 eq.) in dry toluene (5 mL) was added dropwise and
the reaction was heated at 110 °C overnight. Removal of the
solvent under reduced pressure yielded the crude product as a
dark brown oil. Purification by flash chromatography eluting
with EtOAc/cyclohexane (1 : 1) gave the corresponding products
11.
((2R,5S,10bR)-2-Phenyl-1,5,6,10b-tetrahydro-2H-isoxazolo[3,2-
a]isoquinolin-5-yl)methanol (11a). Following the general pro-
cedure, reaction of styrene (2.8 mmol, 322 μL) with nitrone 3
gave the cycloadduct 11a (26 mg, 86% yield) as a yellow oil;
[α]25D −29 (c = 3.6, CHCl3); IR (ATR): ν = 3372, 3027, 2937, 2886,
1733, 1241, 1047, 927, 794, 699 cm−1; 1H NMR (400 MHz,
CDCl3): δH = 7.46–7.43 (m, 2H), 7.42–7.37 (m, 2H), 7.36–7.31
(m, 1H), 7.21–7.14 (m, 3H), 7.09–7.07 (m, 1H), 5.44 (dd, J = 9.5,
4.5 Hz, 1H), 4.88 (dd, J = 10.3, 8.2 Hz, 1H), 3.94–3.93 (m, 2H),
3.35–3.30 (m, 1H), 2.97 (dd, J = 16.4, 11.5 Hz, 1H), 2.82–2.72
(m, 2H), 2.68–2.62 (m, 1H) ppm; 13C NMR (101 MHz, CDCl3):
δC = 141.1, 134.7, 132.2, 128.6, 128.2, 128.0, 127.0, 126.9,
126.4, 79.1, 66.2, 64.1, 56.9, 45.5, 31.5 ppm; HRMS
(ESI-EtOAc): m/z calcd for C18H19NO2 [M + H]
+: 282.1494 found
282.1489.
((2S,5S,10bR)-2-Butyl-1,5,6,10b-tetrahydro-2H-isoxazolo[3,2-a]
isoquinolin-5-yl)methanol (11b). Following the general pro-
cedure reaction of 1-hexene (2.8 mmol, 350 μL) with nitrone 3
gave the cycloadduct 11b (17 mg, 74% yield) as a yellow oil;
[α]25D −6 (c = 1, CHCl3); IR (ATR): ν = 3405, 2953, 2858, 1454,
1050, 944, 748, 713 cm−1; 1H NMR (400 MHz, CDCl3): δH =
7.20–7.14 (m, 2H), 7.10–7.09 (m, 2H), 4.60 (t, J = 9.2, 1H), 4.41
(dq, J = 12.6, 6.1 Hz, 1H), 3.86–3.85 (m, 2H), 3.29 (br s, 1H),
3.20–3.14 (m, 1H), 2.85 (dd, J = 16.3, 11.6 Hz, 1H), 2.70 (dd, J =
16.4, 3.6 Hz, 1H), 2.40–2.31 (m, 2H), 1.72–1.66 (m, 1H), 1.64
(m, 1H), 1.44–1.30 (m, 4H), 0.92 (t, J = 6.9 Hz, 3H) ppm;
13C NMR (101 MHz, CDCl3): δC = 135.3, 132.2, 128.3, 127.1,
126.8, 126.4, 77.6, 66.7, 63.9, 56.5, 42.4, 35.0, 31.6, 28.2,
22.8, 14.1 ppm; HRMS (ESI-EtOAc): m/z calcd for C16H23NO2
[M + H]+: 262.1807 found 262.1802.
((2R,5S,10bR)-2-(2-(Benzyloxy)ethyl)-1,5,6,10b-tetrahydro-2H-
isoxazolo[3,2-a]isoquinolin-5-yl)methanol (11c). Following the
general procedure, reaction of 4-benzyloxybut-1-ene18
(2.8 mmol, 454 mg) with nitrone 3 gave the cycloadduct 11c
(42 mg, 61% yield) as a yellow oil. [α]25D −1.21 (c = 9.9, CHCl3);
IR (ATR): ν = 3421, 3027, 2916, 2882, 1454, 1361, 1096, 910,
733, 697 cm−1; 1H NMR (400 MHz, CDCl3): δH = 7.38–7.27 (m,
5H), 7.21–7.15 (m, 2H), 7.12–7.07 (m, 2H), 4.64–4.55 (m, 2H),
4.52 (s, 2H), 3.86 (d, 4.2 Hz, 2H), 3.65–3.60 (m, 2H), 3.24 (br s,
1H), 3.17 (ddd, J = 11.7, 7.9, 4.0 Hz, 1H), 2.88 (dd, J = 16.3, 11.6
Hz, 1H), 2.72 (dd, J = 16.4, 3.6 Hz, 1H), 2.48–2.36 (m, 2H),
2.05–1.92 (m, 2H) ppm; 13C NMR (101 MHz, CDCl3): δC =
138.1, 135.0, 132.1, 128.3, 128.1, 127.6, 127.5, 126.9, 126.7,
126.2, 77.2, 74.8, 73.1, 66.9, 66.1, 63.6, 56.5, 42.2, 35.2,
31.4 ppm; HRMS (ESI-EtOAc): m/z calcd for C21H25NO3
[M + H]+: 340.1913 found 340.1907.
((2R,5S,10bR)-2-(2-(Phenylthio)ethyl)-1,5,6,10b-tetrahydro-2H-
isoxazolo[3,2-a]isoquinolin-5-yl)methanol (11d). Following the
general procedure, reaction of but-3-en-1-yl(phenyl)sulfane19
(2.8 mmol, 459 mg) with nitrone 3 gave the cycloadduct 11d
(50 mg, 64% yield) as a yellow oil. [α]25D −91 (c = 1, CHCl3); IR
(ATR): ν = 3408, 3058, 2930, 2884, 1582, 1438, 1051, 1024, 944,
736, 690 cm−1; 1H NMR (400 MHz, CDCl3): δH = 7.37–7.35 (m,
2H), 7.32–7.28 (m, 2H), 7.21–7.06 (m, 5H), 4.63–4.54 (m, 2H),
3.86 (s, 2H), 3.19–3.07 (m, 3H), 2.99 (ddd, J = 13.1, 8.3, 7.2 Hz,
1H), 2.88 (dd, J = 16.2, 11.6 Hz, 1H), 2.72 (dd, J = 16.4, 3.6 Hz,
1H), 2.45–2.30 (m, 2H), 2.08–1.91 (m, 2H) ppm; 13C NMR
(101 MHz, CDCl3): δC = 135.8, 134.8, 132.1, 129.2, 128.9, 128.1,
126.9, 126.8, 126.3, 126.1, 75.7, 66.1, 63.7, 56.7, 42.1, 34.7,
31.4, 29.9 ppm; HRMS (ESI-EtOAc): m/z calcd for C20H23NO2S
[M + H]+: 342.1528 found 342.1522.
General procedure for the reduction of cycloadducts 1116
Zinc dust (5.0 eq.) was added to a solution of cycloadduct 11
(1 eq.) in 50% acetic acid : water at room temperature. The
mixture was stirred under reflux for 3 h. After cooling, the
mixture was neutralized with saturated aqueous NaHCO3 and
the aqueous phase was extracted with CH2Cl2 (3 × 10 mL). The
combined organic phases were dried over MgSO4, concen-
trated under reduced and the residue purified by column
chromatography.
(R)-2-((1R,3S)-3-(Hydroxymethyl)-1,2,3,4-tetrahydroisoquino-
lin-1-yl)-1-phenylethanol (12a). Following the general pro-
cedure, reduction of cycloadduct 11a (50 mg, 0.18 mmol) gave
1,3-disubstituted THIQ 12a (17 mg, 33% yield) as a yellow oil.
[α]25D −0.42 (c = 2.4, CHCl3); IR (ATR): ν = 3300, 3060, 3024,
2918, 1655, 1450, 1057, 1028, 743, 700 cm−1; 1H NMR
(400 MHz, CDCl3): δH = 7.45 (d, J = 7.4 Hz, 2H), 7.35 (t, J =
7.6 Hz, 2H), 7.27–7.23 (m, 1H), 7.12–7.03 (m, 3H), 6.82–6.80
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(m, 1H), 5.09 (t, J = 4.3 Hz, 1H), 4.4 (br s, 2H), 4.17 (dd, J =
11.2, 2.2 Hz, 1H), 3.76 (dd, J = 11.1, 3.8 Hz, 1H), 3.59 (dd, J =
11.2, 6.3 Hz, 1H), 3.30–3.24 (m, 1H), 2.69 (dd, J = 16.5, 4.2 Hz,
1H), 2.56 (dd, J = 16.4, 10.7 Hz, 1H), 2.44 (ddd, J = 14.8, 11.4,
3.6 Hz, 1H), 1.98 (ddd, J = 14.7, 5.2, 2.8 Hz, 1H), ppm; 13C
NMR (101 MHz, CDCl3): δC = 144.7, 138.0, 134.0, 129.4, 128.2,
126.7, 126.2, 125.9, 125.4, 72.3, 65.1, 51.5, 48.6, 41.8,
30.4 ppm; HRMS (ESI-EtOAc): m/z calcd for C18H21NO2
[M + H]+: 284.1651 found 284.1645.
(S)-1-((1R,3S)-3-(Hydroxymethyl)-1,2,3,4-tetrahydroisoquinolin-
1-yl)hexan-2-ol (12b). Following the general procedure,
reduction of cycloadduct 11b (17 mg, 0.07 mmol) gave 1,3-di-
substituted THIQ 12b (16 mg, 90% yield) as a yellow oil.
[α]25D −0.21 (c = 4.7, CHCl3); IR (ATR): ν = 3310, 3062, 2926,
2857, 1452, 1123, 1035, 743 cm−1; 1H NMR (400 MHz, CDCl3):
δH = 7.14–7.01 (m, 4H), 4.43 (dd, J = 10.8, 2.4 Hz, 1H), 3.82 (br
s, 3H), 3.70 (dd, J = 11.1, 3.7 Hz, 1H), 3.54 (dd, J = 11.0, 7.3 Hz,
1H), 3.26–3.20 (m, 1H), 2.73 (dd, J = 16.4, 4.1 Hz, 1H), 2.56 (dd,
J = 16.4, 10.2 Hz, 1H), 2.10 (ddd, J = 14.2, 11.3, 3.0 Hz, 1H),
1.73–1.61 (m, 2H), 1.56–1.1.25 (m, 6H), 0.91 (t, J = 6.9 Hz, 3H)
ppm; 13C NMR (101 MHz, CDCl3): δC = 138.3, 133.8, 129.4,
126.3, 126.2, 126.0, 69.4, 64.8, 51.3, 48.9, 40.3, 36.8, 30.5, 28.3,
22.8, 14.1 ppm; HRMS (ESI-EtOAc): m/z calcd for C16H25NO2
[M + H]+: 264.1964 found 264.1958.
(R)-4-(Benzyloxy)-1-((1R,3S)-3-(hydroxymethyl)-1,2,3,4-tetra-
hydroisoquinolin-1-yl)butan-2-ol (12c). Following the general
procedure, reduction of cycloadduct 11c (27 mg, 0.08 mmol)
gave 1,3-disubstituted THIQ 12c (14 mg, 51% yield) as a yellow
oil. [α]25D −0.31 (c = 3.2, CHCl3); IR (ATR): ν = 3298, 3061, 3028,
2916, 2857, 1452, 1362, 1090, 1027, 740, 697 cm−1; 1H NMR
(400 MHz, CDCl3): δH = 7.28–7.18 (m, 5H), 7.06–6.89 (m, 4H),
4.43 (s, 2H), 4.36 (dd, J = 10.9, 2.5 Hz, 1H), 4.01–3.92 (m, 4H),
3.64 (dd, J = 11.2, 3.8 Hz, 1H), 3.53 (t, J = 6.1 Hz, 2H), 3.45 (dd,
J = 11.1, 7.4 Hz, 1H), 3.20–3.14 (m, 1H), 2.64 (dd, J = 16.5, 4.3
Hz, 1H), 2.49 (dd, J = 16.5, 10.4 Hz, 1H), 2.02–1.95 (m, 1H),
1.88–1.81 (m, 1H), 1.78–1.64 (m, 2H) ppm; 13C NMR (101 MHz,
CDCl3): δC = 138.4, 138.2, 133.7, 129.5, 128.5, 127.9, 127.8,
126.6, 126.5, 126.2, 73.4, 68.5, 67.8, 64.9, 51.4, 49.1, 41.1, 36.8,
30.6 ppm; HRMS (ESI-EtOAc): m/z calcd for C21H27NO3
[M + H]+: 342.2069 found 342.2064.
(R)-1-((1R,3S)-3-(Hydroxymethyl)-1,2,3,4-tetrahydroisoquino-
lin-1-yl)-4-(phenylthio)butan-2-ol (12d). Following the general
procedure, reduction of cycloadduct 11d (47 mg, 0.13 mmol)
gave 1,3-disubstituted THIQ 12d (22 mg, 47% yield) as a white
solid; m.p. 60–62 °C; [α]25D −6 (c = 2, CHCl3); IR (ATR): ν = 3369,
3070, 2919, 1581, 1479, 1437, 1090, 1027, 735, 689 cm−1; 1H
NMR (400 MHz, CDCl3): δH = 7.25 (d, J = 7.4 Hz, 2H), 7.18 (t,
J = 7.6 Hz, 2H), 7.09–7.02 (m, 31H), 7.00–6.97 (m, 1H),
6.92–6.90 (m, 1H), 4.31 (dd, J = 10.8, 2.6 Hz, 1H), 3.94–3.88 (m,
1H), 3.71 (br s, 3H), 3.61 (dd, J = 11.1, 3.8 Hz, 1H), 3.44 (dd, J =
11.1, 7.2 Hz, 1H), 3.16–3.03 (m, 2H), 2.95–2.88 (m, 1H), 2.64
(dd, J = 16.5, 4.3 Hz, 1H), 2.46 (d, J = 16.4, 101 Hz, 1H), 2.02
(ddd, J = 14.2, 11.2, 3.1), 1.96–1.87 (m, 1H), 1.75–1.67 (m, 1H),
1.62 (ddd, J = 14.7, 6.6, 3.1 Hz, 1H) ppm; 13C NMR (101 MHz,
CDCl3): δC = 128.3, 136.6, 133.9, 129.7, 129.0, 128.9, 126.5,
126.4, 126.2, 125.9, 68.6, 65.1, 51.6, 49.0, 40.4, 36.5, 30.7,
30.3 ppm; HRMS (ESI-EtOAc): m/z calcd for C20H25NO2S
[M + H]+: 344.1684 found 344.1679.
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